Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.
2.

RETRACTED: Subcutaneous injections of aluminum at vaccine adjuvant levels activate innate immune genes in mouse brain that are homologous with biomarkers of autism.

Li D, Tomljenovic L, Li Y, Shaw CA.

J Inorg Biochem. 2017 Dec;177:39-54. doi: 10.1016/j.jinorgbio.2017.08.035. Epub 2017 Sep 5. No abstract available. Retraction in: J Inorg Biochem. 2017 Dec;177:247.

3.

Guillian-Barré Syndrome and Acute Disseminated Encephalomyelitis related to the Bivalent Oral Poliovirus Vaccine.

Tomljenovic L.

Isr Med Assoc J. 2016 Oct;18(10):619-622. No abstract available.

4.

Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.

Inbar R, Weiss R, Tomljenovic L, Arango MT, Deri Y, Shaw CA, Chapman J, Blank M, Shoenfeld Y.

Immunol Res. 2017 Feb;65(1):136-149. doi: 10.1007/s12026-016-8826-6.

PMID:
27421722
5.

Postural Orthostatic Tachycardia Syndrome (POTS)--A novel member of the autoimmune family.

Dahan S, Tomljenovic L, Shoenfeld Y.

Lupus. 2016 Apr;25(4):339-42. doi: 10.1177/0961203316629558. Epub 2016 Feb 3.

PMID:
26846691
6.

WITHDRAWN: Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.

Inbar R, Weiss R, Tomljenovic L, Arango MT, Deri Y, Shaw CA, Chapman J, Blank M, Shoenfeld Y.

Vaccine. 2016 Jan 9. pii: S0264-410X(16)00016-5. doi: 10.1016/j.vaccine.2015.12.067. [Epub ahead of print]

PMID:
26778424
7.

The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases.

Baker B, Eça Guimarães L, Tomljenovic L, Agmon-Levin N, Shoenfeld Y.

Expert Opin Drug Saf. 2015;14(9):1387-94. doi: 10.1517/14740338.2015.1073710. Epub 2015 Jul 28. Review.

PMID:
26216756
8.

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

Shaw CA, Li D, Tomljenovic L.

Immunotherapy. 2014;6(10):1055-71. doi: 10.2217/imt.14.81. Review.

PMID:
25428645
9.

Aluminum-induced entropy in biological systems: implications for neurological disease.

Shaw CA, Seneff S, Kette SD, Tomljenovic L, Oller JW Jr, Davidson RM.

J Toxicol. 2014;2014:491316. doi: 10.1155/2014/491316. Epub 2014 Oct 2. Review.

10.

Authors' reply: Human papilloma virus vaccine and primary ovarian failure.

Shoenfeld Y, Tomljenovic L.

Am J Reprod Immunol. 2014 Sep;72(3):260-1. doi: 10.1111/aji.12286. Epub 2014 Jul 1. No abstract available.

PMID:
24981881
11.

Authors' reply: Human papillomavirus vaccine and primary ovarian failure.

Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y.

Am J Reprod Immunol. 2014 Apr;71(4):295-6. doi: 10.1111/aji.12200. Epub 2014 Jan 10. No abstract available.

PMID:
24410950
12.

Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccination as Part of the "Autoimmune/Auto-inflammatory Syndrome Induced by Adjuvants": Case Report and Literature Review.

Tomljenovic L, Colafrancesco S, Perricone C, Shoenfeld Y.

J Investig Med High Impact Case Rep. 2014 Mar 18;2(1):2324709614527812. doi: 10.1177/2324709614527812. eCollection 2014 Jan-Mar.

13.

Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes.

Shaw CA, Li Y, Tomljenovic L.

J Inorg Biochem. 2013 Nov;128:237-44. doi: 10.1016/j.jinorgbio.2013.07.022. Epub 2013 Jul 19.

PMID:
23932735
14.

Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.

Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y.

Am J Reprod Immunol. 2013 Oct;70(4):309-16. doi: 10.1111/aji.12151. Epub 2013 Jul 31. Review.

PMID:
23902317
15.

Association between vaccination and Guillain-Barré syndrome.

Tomljenovic L, Shoenfeld Y.

Lancet Infect Dis. 2013 Sep;13(9):730-1. doi: 10.1016/S1473-3099(13)70142-7. Epub 2013 Jun 28. No abstract available.

PMID:
23810251
16.

Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.

Shaw CA, Tomljenovic L.

Immunol Res. 2013 Jul;56(2-3):304-16. doi: 10.1007/s12026-013-8403-1. Review.

PMID:
23609067
17.

HPV vaccines and cancer prevention, science versus activism.

Tomljenovic L, Wilyman J, Vanamee E, Bark T, Shaw CA.

Infect Agent Cancer. 2013 Feb 1;8(1):6. doi: 10.1186/1750-9378-8-6.

18.

Too fast or not too fast: the FDA's approval of Merck's HPV vaccine Gardasil.

Tomljenovic L, Shaw CA.

J Law Med Ethics. 2012 Fall;40(3):673-81. doi: 10.1111/j.1748-720X.2012.00698.x.

PMID:
23061593
19.

Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?

Tomljenovic L, Spinosa JP, Shaw CA.

Curr Pharm Des. 2013;19(8):1466-87. Review.

PMID:
23016780
20.

Who profits from uncritical acceptance of biased estimates of vaccine efficacy and safety?

Tomljenovic L, Shaw CA.

Am J Public Health. 2012 Sep;102(9):e13-4. doi: 10.2105/AJPH.2012.300837. Epub 2012 Jul 19. No abstract available.

Supplemental Content

Loading ...
Support Center